In a significant step towards globalizing traditional medicine, India and Indonesia signed a Memorandum of Understanding (MoU) to enhance quality assurance, safety, and efficacy in the sector. The MoU was exchanged on January 25, 2025, at Hyderabad House, New Delhi, in the presence of India’s Prime Minister, Mr. Narendra Modi, and Indonesia’s President, Mr. Prabowo Subianto. This agreement marks a milestone in international cooperation for promoting scientifically regulated traditional medicine.

Objective of the India-Indonesia Traditional Medicine MoU

The Ministry of Ayush, Government of India, and the Indonesian Food and Drug Authority signed this MoU with a strategic focus on knowledge exchange, capacity building, and technical collaboration. Union Minister of State for Health and Family Welfare, Mr. Prataprao Ganpatrao Jadhav, emphasized that this partnership will ensure a standardized regulatory framework for traditional medicine, reinforcing its integration into global healthcare systems.

Key objectives include:

• Quality Assurance & Safety: Ensuring scientific validation and standardization of Ayurveda, Unani, Siddha, and Jamu (Indonesian traditional medicine).
• Regulatory Collaboration: Strengthening herbal medicine safety, including regulatory best practices.
• Technical & Training Programs: Encouraging technical visits, knowledge-sharing workshops, and joint research projects.
• International Participation: Promoting collaborative efforts in global healthcare forums to highlight the role of traditional medicine.

Strengthening Global Traditional Medicine Standards

According to Secretary, Ministry of Ayush, Mr. Vaidya Rajesh Kotecha, the MoU will facilitate technical exchanges, regulatory discussions, and research collaborations. India’s extensive experience in Ayurvedic research and standardization will complement Indonesia’s traditional medicine industry, allowing both countries to harmonize quality control practices.

This agreement also aligns with global initiatives such as the World Health Organization (WHO) Traditional Medicine Strategy, which emphasizes the safe and effective integration of traditional medicine into modern healthcare.

A Milestone for India’s Traditional Medicine Sector

This MoU adds to India’s growing efforts in promoting Ayush systems on the global stage. It follows similar agreements signed with the USA, Japan, and other ASEAN countries, reinforcing India's commitment to scientific validation and international acceptance of traditional medicine.

By collaborating with Indonesia, India strengthens its diplomatic and economic ties while ensuring that Ayurveda, Unani, and other traditional medicine systems gain broader global recognition. This partnership marks a significant step towards making traditional medicine a mainstream healthcare solution worldwide.

Conclusion

The India-Indonesia MoU on Traditional Medicine Quality Assurance is a historic step in global healthcare collaboration. By focusing on scientific validation, safety, and international cooperation, both nations are setting new benchmarks for herbal and traditional medicine. This partnership not only strengthens India’s Ayush sector but also helps in expanding traditional medicine’s role in global health policies.

The Upcoming IPOs in this week and coming weeks are Royalarc Electrodes Limited, Tejas Cargo India Limited, Quality Power Electrical Equipments.

The Current active IPO are  L.K. Mehta, Shanmuga Hospital, PS Raj Steels, Voler Car, Maxvolt Energy, Hexaware Technologies.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.

Join our Finance Saathi Telegram Channel for Regular Share Market, News & IPO Update.